Clearside biomedical announces completion of final participant visit in odyssey phase 2b trial of cls-ax in wet amd

- cls-ax is a highly potent tyrosine kinase inhibitor delivered suprachoroidally using clearside's proprietary scs microinjector ® -

CLS Ratings Summary

CLS Quant Ranking